Published January 2015 |
109 Pages |
73 Exhibits |
Forecasts Through 2020
Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This analy...
Published January 2015 |
94 Pages |
46 Exhibits |
Forecasts Through 2020
The global market for surgical drapes and gowns, gloves, masks, and fluid management products was valued at $9.5 billion in 2014. As analyzed in this detailed new analysis by LSI, the market will be influenced by efforts to limit health care costs through the reduction of infections and product expenditures as well as the need to accommodate the rising number of surgeries in key markets. Trends in product utilization, such as double-gloving, will generate growth in the number of units sold each...
Published January 2015 |
85 Pages |
41 Exhibits |
Forecasts Through 2019
The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the effe...
Published January 2015 |
72 Pages |
31 Exhibits |
Forecasts Through 2019
Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs),...
Published January 2015 |
82 Pages |
46 Exhibits |
Forecasts Through 2019
The global market for peripheral vascular stents, which was valued at $1.1 billion in 2013, has entered into a dynamic phase which will be characterized by the rising prevalence of peripheral artery disease (PAD), growing availability in key regional markets, and the adoption of potentially competitive products, such as drug-coated balloons (DCBs). In the U.S., where DCBs became commercially available in October 2014, the use of stents will continue to be driven by the availability of products t...
Published January 2015 |
94 Pages |
57 Exhibits |
Forecasts Through 2020
The global market for oxygen therapy and inhalation devices was valued at $1.0 billion in 2014. As analyzed in this detailed new report by LSI, growth in developed markets, such as the U.S., has been profoundly shaped by trends in reimbursement. While cost-containment efforts by providers have threatened product manufacturers' margins, they have also spurred the adoption of technologies that reduce the need for frequent visits and facilitate more flexible lifestyles for patients, trends which wi...
Published January 2015 |
105 Pages |
53 Exhibits |
Forecasts Through 2019
The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of transradial access-f...
Published January 2015 |
214 Pages |
72 Exhibits |
Forecasts Through 2019
All of our reports are available via individual purchase or as part of a subscription to our Medtech Pro platform, which includes a full library of reports.
Published January 2015 |
200 Pages |
75 Exhibits |
Forecasts Through 2019
This report covers the novel drug-coated balloon and drug-eluting stent technologies that are expected to trigger a paradigm shift in treatment of advanced peripheral artery disease-particularly lower extremity occlusions-driving the development of a new multi-billion dollar market. Also covered in the report are revascularization-enabling peripheral atherectomy systems and dedicated refractory CTO crossing devices that are projected to see above-average growth through 2019.
Published January 2014 |
27 Pages |
30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in March 2014. Additionally, read LSI's "Innovator of the Month" Interview with:
- Daniel Burnett, MD, President & CEO, TheraNova, LLC
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Biomaterials Companies- B...
Published January 2014 |
30 Pages |
30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in April 2014. Additionally, read LSI's "Innovator of the Month" Interview with:
- Raymond W. Cohen, CEO and Board Member, Axonics Modulation Technologies
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Bioma...
Published January 2014 |
29 Pages |
30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in May 2014. Additionally, read LSI's "Innovator of the Month" Interview with:
- Amir Belson, M.D.
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Biomaterials Companies- Biotechnology/Cell Therapy Companies-...
Published January 2014 |
28 Pages |
30 Exhibits |
This report includes details on 30 emerging medical technology companies that have been identified by LSI's in-house research team in June 2014. Additionally, read LSI's "Innovator of the Month" Interview with:
- Fred Khosravi
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Biomaterials Companies- Biotechnology/Cell Therapy Companies- Ca...
Published January 2014 |
11 Pages |
21 Exhibits |
This report includes details on 21 emerging medical technology companies that have been identified by LSI's in-house research team in July/August 2014. All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Biomaterials Companies- Biotechnology/Cell Therapy Companies- Cardiovascular Companies- Dental Companies- Diagnostics Companies- Drug Deliv...
Published January 2014 |
53 Pages |
60 Exhibits |
This report includes details on 60 emerging medical technology companies that have been identified by LSI's in-house research team in January 2014. Additionally, read LSI's "Innovator of the Month" Interview with:
- Uday Kumar, M.D., Cardiologist, Electrophysiologist, and Entrepreneur
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:- Aesthetics/Dermatology Companies- Bioma...
